Goldman Sachs
VINC

Goldman Sachs’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Goldman Sachs’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,567
Closed -$16.7K – 6588
2025
Q1 		$16.7K Sell
31,567
-3
-0% -$5 ﹤0.01% 5951
2024
Q4 		$166K Sell
31,570
-1
-0% -$7 ﹤0.01% 5687
2024
Q3 		$452K Hold
31,571
– – ﹤0.01% 5102
2024
Q2 		$511K Sell
31,571
-4
-0% -$100 ﹤0.01% 4822
2024
Q1 		$3.2M Sell
31,575
-53,908
-63% -$3.41M ﹤0.01% 3495
2023
Q4 		$2.02M Sell
85,483
-17,663
-17% -$297K ﹤0.01% 3924
2023
Q3 		$2.08M Sell
103,146
-2
-0% -$39 ﹤0.01% 3741
2023
Q2 		$2.68M Sell
103,148
-97
-0.1% -$2.78K ﹤0.01% 3645
2023
Q1 		$2.15M Sell
103,245
-469
-0.5% -$10.5K ﹤0.01% 3804
2022
Q4 		$2.12M Buy
103,714
+103,019
+14,823% +$1.94M ﹤0.01% 3904
2022
Q3 		$19K Sell
695
-1,111
-62% -$32K ﹤0.01% 5949
2022
Q2 		$48K Buy
1,806
+316
+21% +$14.1K ﹤0.01% 6036
2022
Q1 		$119K Buy
+1,490
New +$184K ﹤0.01% 6049

Other funds holding VINC

BTC
Bank & Trust Company Litchfield, Illinois $158M AUM 35.48% 1-Year Est. Return

Goldman Sachs's VINC Position: Q2 2025 in Review

Goldman Sachs sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2025, closing a stake of 31,567 shares — an estimated $16.7K sold.

Goldman Sachs first reported a position in VINC in Q1 2022 and held it in 13 quarters. The position peaked at $3.2M in Q1 2024. 1 fund tracked by Wall St. Rank holds VINC as of Q2 2025.

  • Goldman Sachs reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Goldman Sachs sold 31,567 Vincerx Pharma, Inc. Common Stock shares in Q2 2025, an estimated $16.7K.
  • Goldman Sachs first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2022 and held it in 13 quarters.
  • Goldman Sachs's Vincerx Pharma, Inc. Common Stock position peaked at $3.2M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.